Indication
REM Sleep Behavior Disorder
6 clinical trials
6 products
Product
PXS-4728Clinical trial
A Phase 2a, Multi Centre, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of 12 Weeks Treatment With Oral PXS-4728A on Microglia Activation, as Measured by Positron Emission Tomography, in Participants With Isolated Rapid Eye Movement Sleep Behavior DisorderStatus: Recruiting, Estimated PCD: 2024-09-30
Product
Matching PlaceboClinical trial
The Effect of Adrenergic Blocker Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's DiseaseStatus: Recruiting, Estimated PCD: 2024-08-01
Product
CarvedilolClinical trial
The Effect of Adrenergic Blocker Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease: A Follow up StudyStatus: , Estimated PCD: 2025-12-30
Clinical trial
The Effect of alpha1- Adrenergic Receptor Antagonist Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease: A Follow up StudyStatus: Recruiting, Estimated PCD: 2025-11-01
Product
TerazosinClinical trial
Implementing a National Biobank of Genetic, Sporadic and Prodromic Parkinson's Disease With Whole Genome Analysis and Functional Assessment of Polygenic Inheritance by iPSC TechnologyStatus: Not yet recruiting, Estimated PCD: 2025-05-01
Product
Whole Genome SequencingClinical trial
Myocardial 123I-MIBG Scintigraphy in Aging and Neurodegenerative DiseaseStatus: , Estimated PCD: 2025-09-01